https://www.selleckchem.com/products/vx-661.html
the large study cohort, vancomycin duration itself was not an independent predictor of mortality. Post-vancomycin SCr elevation appeared to be a driver of in-hospital mortality. Even a 10% SCr increase from baseline prior to vancomycin infusion was associated with increased mortality risk. This finding stresses the importance of closely monitoring renal function and may support the value of pharmacokinetic dosing.Dynamic DNA nanodevices represent powerful tools for the interrogation and manipulation of biological systems. Yet, implementa
Like
Comment
Share
